Gastric cancer: p-mTOR a more valuable prognostic marker than mTOR

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • In gastric cancer (GC) phosphorylated mammalian target of rapamycin (p-mTOR) is a more valuable prognostic marker than mTOR.

Why this matters

  • Novel prognostic biomarker for GC urgently needed.

Key results

  • mTOR, p-mTOR, p70S6k, and p-p70S6K expression rates were 60.8%, 54...